NIKKEI 225
38,835.10 +599.03 (+1.57%) HANG SENG
18,479.37 -98.93 (-0.53%) CRUDE OIL
78.92 +0.44 (+0.56%) GOLD FUTURES
2,323.80 -7.40 (-0.32%) DOW
38,912.99 +60.72 (+0.16%) Bitcoin GBP
50,679.31 +348.11 (+0.69%)
Enanta Pharmaceuticals, Inc. (9EP.F)
| Previous close | 13.30 |
| Open | 13.50 |
| Bid | 11.70 x 15600 |
| Ask | 12.00 x 15300 |
| Day's range | 13.50 - 13.50 |
| 52-week range | 7.50 - 25.60 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 291.244M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -6.11 |
| Earnings date | 05 Aug 2024 - 09 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 65.33 |
Insider MonkeyEnanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q2 2024 Earnings Call Transcript
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q2 2024 Earnings Call Transcript May 6, 2024 Enanta Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to Enanta Pharmaceuticals’ Fiscal Second Quarter Financial Results Conference Call. At this time, […]
- Thomson Reuters StreetEvents
Q2 2024 Enanta Pharmaceuticals Inc Earnings Call
Q2 2024 Enanta Pharmaceuticals Inc Earnings Call
Business WireEnanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference
WATERTOWN, Mass., May 07, 2024--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, and Tara L. Kieffer, Ph.D., Chief Product Strategy Officer, will participate in a fireside chat at the JMP Securities Life Sciences Conference on May 14, 2024 at 10:00 a.m. ET in New York, NY.
